Radius Health Inc. (RDUS)

30.54
NASDAQ : Health Technology
Prev Close 30.74
Day Low/High 30.39 / 31.33
52 Wk Low/High 24.66 / 49.16
Avg Volume 681.60K
Exchange NASDAQ
Shares Outstanding 45.46M
Market Cap 1.40B
EPS -5.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

First Week of RDUS March 16th Options Trading

First Week of RDUS March 16th Options Trading

Investors in Radius Health Inc saw new options begin trading this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

Interesting RDUS Put And Call Options For February 2018

Interesting RDUS Put And Call Options For February 2018

Investors in Radius Health Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

France-based firm said its Phase 2 study of eryaspase (Graspa) in acute myeloid leukemia did not achieve its primary endpoint of overall survival.

First Week of December 15th Options Trading For Radius Health (RDUS)

First Week of December 15th Options Trading For Radius Health (RDUS)

Investors in Radius Health Inc saw new options begin trading this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new December 15th contracts and identified one put and one call contract of particular interest.